128 related articles for article (PubMed ID: 11735291)
1. Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance.
Wodarz D
J Theor Biol; 2001 Dec; 213(3):447-59. PubMed ID: 11735291
[TBL] [Abstract][Full Text] [Related]
2. The persistence of CTL memory.
Wodarz D
Neth J Med; 2002 Aug; 60(7 Suppl):4-13; discussion 14-6. PubMed ID: 12430586
[TBL] [Abstract][Full Text] [Related]
3. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
Wodarz D; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
[TBL] [Abstract][Full Text] [Related]
4. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.
Altes HK; Wodarz D; Jansen VA
J Theor Biol; 2002 Feb; 214(4):633-46. PubMed ID: 11851372
[TBL] [Abstract][Full Text] [Related]
5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
6. A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.
Wodarz D; Page KM; Arnaout RA; Thomsen AR; Lifson JD; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):329-43. PubMed ID: 10794051
[TBL] [Abstract][Full Text] [Related]
7. The role of T cell help for anti-viral CTL responses.
Wodarz D; Jansen VA
J Theor Biol; 2001 Aug; 211(4):419-32. PubMed ID: 11476625
[TBL] [Abstract][Full Text] [Related]
8. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
Geels MJ; Jansen CA; Baan E; De Cuyper IM; van Schijndel GJ; Schuitemaker H; Goudsmit J; Pollakis G; Miedema F; Paxton WA; van Baarle D
Virology; 2006 Feb; 345(1):209-19. PubMed ID: 16246391
[TBL] [Abstract][Full Text] [Related]
9. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of HIV persistence: implications for vaccines and therapy.
Bremermann HJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):459-83. PubMed ID: 7627623
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
[TBL] [Abstract][Full Text] [Related]
13. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS.
Wasik TJ; Wierzbicki A; Whiteman VE; Trinchieri G; Lischner HW; Kozbor D
Eur J Immunol; 2000 Jan; 30(1):117-27. PubMed ID: 10602033
[TBL] [Abstract][Full Text] [Related]
14. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
15. Defining CTL-induced pathology: implications for HIV.
Wodarz D; Krakauer DC
Virology; 2000 Aug; 274(1):94-104. PubMed ID: 10936092
[TBL] [Abstract][Full Text] [Related]
16. Similar HIV-1 evolution and immunological responses at 10 years despite several therapeutic strategies and host HLA Types.
Arnedo-Valero M; Plana M; Mas A; Guilà M; Gil C; Castro P; Garcia F; Domingo E; Gatell JM; Pumarola T
J Med Virol; 2004 Aug; 73(4):495-501. PubMed ID: 15221891
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) T helper cells and the role they play in viral control.
Norris PJ; Rosenberg ES
J Mol Med (Berl); 2002 Jul; 80(7):397-405. PubMed ID: 12110945
[TBL] [Abstract][Full Text] [Related]
18. A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment.
Shi V; Tridane A; Kuang Y
J Theor Biol; 2008 Jul; 253(1):24-35. PubMed ID: 18083195
[TBL] [Abstract][Full Text] [Related]
19. A model predictive control based scheduling method for HIV therapy.
Zurakowski R; Teel AR
J Theor Biol; 2006 Jan; 238(2):368-82. PubMed ID: 15993900
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.
Smith RJ; Wahl LM
Bull Math Biol; 2005 Jul; 67(4):783-813. PubMed ID: 15893553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
